A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents

Clinical trial NCT05102591 · COMPLETED

Trial details

NCT number: NCT05102591
Sponsor: University of Calgary
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine Disorders

Start date: 2022-02-22
Primary completion: 2024-03-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.